Nov 29, 2019 – EOS imaging announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new generation imaging system, EOSedge (Europe, Canada and Australia).
New system will be unveiled in Radiological Society of North America (RSNA) 2019 Annual Meeting which is going to be held on December 1st, in Chicago.EOSedge is the first general X-ray system motorized by a high-resolution photon counting detector, delivering optimal image quality for outstanding musculoskeletal imaging exams. Flex Dose™ technology by
EOSedge in order to modulate radiation dose along the patient’s body, as well as an open cabin with a motorized, enlarged patient platform to facilitate easy and comfortable access for a broad range of patients in order to deliver larger fields of examination.
EOSedge and the first-generation EOS system are designed to work flawlessly with the Advanced Orthopedic Solutions, that include 3DServices, EOSapps 3D surgical planning for spine, hip and knee as well as EOSlink™, which delivers the EOS surgical plan into the operating room to be used with advanced surgical technologies. https://www.eos-imaging.us/sites/default/files/press-release/PR_EOS%20imaging_FDA%20Clearance_29.11.19_EN_vf_0.pdf